Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

U.S. stocks mixed ahead of economic reports; Dow Jones down 0.14%

Published 06/24/2014, 09:39 AM
Updated 06/24/2014, 09:39 AM
U.S. stocks open mixed, eyes on data

Investing.com - U.S. stocks opened mixed on Tuesday, as markets were jittery ahead of upcoming U.S. economic reports as Monday's upbeat U.S. data did little to support sentiment.

During early U.S. trade, the Dow 30 slipped 0.14%, the S&P 500 edged down 0.12%, while the NASDAQ Composite rose 0.20%.

On Monday, the National Association of Realtors said that U.S. existing home sales increased 4.9% to a seven-month high of 4.89 million units last month from 4.66 million in April. Analysts had expected existing home sales to rise 2.2% to 4.73 million units in May.

Separately, market research group Markit said that its preliminary U.S. manufacturing purchasing managers’ index rose to a four-year high of 57.5 this month from a final reading of 56.4 in May. Analysts had expected the index to ease down to 56.1 in June.

Walgreen (NYSE:WAG) tumbled 1.49% after the drugstore chain reported a 16% rise in its fiscal third-quarter earnings, still below market expectations.

Dean Foods (NYSE:DF) added to losses, dropping 0.68%, after the Wall Street Journal reported that Federal authorities asked for information related to an insider-trading probe of investor Carl Icahn from the food-and-beverage supplier.

Elsewhere, Avon Products (NYSE:AVP) shares retreated 0.54% after the cosmetics seller said it plans to cut 600 jobs in a bid to reduce costs and restore profitability. According to the company, the job cuts should save $50 million to $55 million a year before taxes.

Gap (NYSE:GPS) slipped 0.19% after announcing that employment applications at Gap and Old Navy chains have climbed by at least 10% from a year earlier. The news came in the wake of the retailer's plans in February to increase hourly wages to $10 by 2015.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

In M&A news, Abbott Laboratories (NYSE:ABT), down 0.27%, confirmed late Monday that it had agreed to buy Russian drug maker Veropharm.

On the upside, Monsanto (NYSE:MON) shares gained 0.47% amid reports it is considering a takeover bid for Swiss agricultural firm Syngenta (SIX:SYNN).

Across the Atlantic, European stock markets were mixed. The DJ Euro Stoxx 50 dipped 0.03%, France’s CAC 40 added 0.13%, Germany's DAX inched 0.04% higher, while Britain's FTSE 100 fell 0.22%.

During the Asian trading session, Hong Kong's Hang Seng rose 0.33%, while Japan’s Nikkei 225 inched up 0.05%.

Later in the day, the U.S. was to release private sector data on consumer confidence, as well as a report on new home sales.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.